Immediate Impact
68 standout
Citing Papers
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
Colorectal cancer
2024 Standout
Works of S. Tsousis being referenced
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S. Tsousis | 313 | 64 | 132 | 133 | 8 | 383 | |
| Sho Tachino | 254 | 52 | 102 | 122 | 6 | 400 | |
| Gairong Zhang | 285 | 63 | 151 | 142 | 8 | 446 | |
| JL Molitor | 352 | 73 | 118 | 114 | 9 | 422 | |
| D. Mari | 246 | 187 | 143 | 28 | 14 | 390 | |
| Robert Goslin | 304 | 126 | 110 | 125 | 5 | 408 | |
| Joseph Fortner | 310 | 215 | 72 | 92 | 7 | 427 | |
| E. Batiste-Alentorn | 258 | 208 | 169 | 19 | 11 | 455 | |
| Jonathan Derman | 289 | 66 | 122 | 57 | 7 | 452 | |
| Takanori Tanase | 345 | 30 | 239 | 45 | 8 | 439 | |
| J Lokich | 337 | 86 | 96 | 54 | 7 | 405 |
All Works
Loading papers...